CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical DevelopmentCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 -- CENTOGENE N.V. , the essential...
Source: marketscreener.com